FindTrial
Sign In

Treatment of Hepatic Epithelioid Hemangioendothelioma: A single-Institution Experience

Treatment of Hepatic Epithelioid Hemangioendothelioma: A single-Institution Experience

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060969
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Epithelioid Hemangioendothelioma

Interventions

Case series:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who received surgical treatment in our center from January 1, 2011 to December 31, 2021 and were confirmed by postoperative pathological diagnosis as hepatic epithelioid hemangioendothelioma

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical symptoms;Demographic characteristic;Imaging data;Pathological diagnosis;Complications;Prognosis;—

Countries

China

Contacts

Public ContactFengLei

West China Hospital of Sichuan University

743538823@qq.com18780240137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026